Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
9/11/19 12:35 | 9/11/19 | RARE | Health | Drug | Pharmaceutical Preparations | Kakkis Emil D | CA | DO | P,CEO | P | 218 | 43.63 | 0 | 5 | 0 | 3,032 | D | ||||||||||||||
8/29/17 16:30 | 8/28/17 | RARE | Health | Drug | Pharmaceutical Preparations | Kakkis Emil D | CA | DO | P,CEO | P | 394 | 52.52 | 0 | 8 | 0 | 2,990 | I | ||||||||||||||
2/5/14 18:59 | 1/31/14 | RARE | Health | Drug | Pharmaceutical Preparations | Fmr LLC | MA | TH | Edward C | P.d | 3,675 | 21.00 | 33 | 175 | 6 | 3,260 | I | 3 | 11 | 50 | 0 | 34 | 52 | ||||||||
2/3/14 20:37 | 1/30/14 | RARE | Health | Drug | Pharmaceutical Preparations | Sharp Shalini | CA | O | CFO,SVP | P | 95 | 21.00 | 33 | 5 | 6 | 84 | D | -7 | -4 | 45 | -1 | 8 | 42 | ||||||||
2/3/14 20:34 | 1/30/14 | RARE | Health | Drug | Pharmaceutical Preparations | Fust Matthew K | CA | D | P.d | 105 | 21.00 | 33 | 5 | New | 5 | D | -7 | -4 | 45 | -1 | 8 | 42 | |||||||||
2/3/14 20:32 | 1/30/14 | RARE | Health | Drug | Pharmaceutical Preparations | Kassberg Thomas Richard | CA | O | Chief Bu | P | 32 | 21.00 | 33 | 2 | 2 | 94 | D | -7 | -4 | 45 | -1 | 8 | 42 | ||||||||
2/3/14 20:21 | 1/30/14 | RARE | Health | Drug | Pharmaceutical Preparations | Aliski William | CA | D | P.d | 105 | 21.00 | 33 | 5 | 16 | 37 | D | -7 | -4 | 45 | -1 | 8 | 42 |
D | Derivative transaction in filing (usually option exercise) |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
A | Amended filing |
E | Error detected in filing |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |